Emergent BioSolutions (EBS) Net Equity Issued and Repurchased (2009 - 2026)
Emergent BioSolutions (EBS) reported Net Equity Issued and Repurchased of -$8 million for Q2 2026, compared with -$6.2 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For FY2025, Emergent BioSolutions posted Net Equity Issued and Repurchased of -$24.9 million.
- By year, Net Equity Issued and Repurchased came in at $14.9 million in FY2024 (+46.1%), $10.2 million in FY2023, -$77.1 million in FY2022 and -$90.1 million in FY2021.
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$102.6 million in Q4 2021 and a high of $13.4 million in Q3 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$8.6 million (Q1 2026), -$10.1 million (Q4 2025) and -$8.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Emergent BioSolutions | 309.85 Mn | -371.25 Mn | 29.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.00 Mn |
| Mar 31, 2026 | -8.60 Mn |
| Dec 31, 2025 | -10.10 Mn |
| Sep 30, 2025 | -8.70 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 13.40 Mn |
| Jun 30, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Jun 30, 2023 | 9.50 Mn |
| Dec 31, 2022 | 873.50 Mn |
| Jun 30, 2022 | -21.90 Mn |
| Mar 31, 2022 | -57.00 Mn |
| Dec 31, 2021 | 829.40 Mn |
| Sep 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 3.10 Mn |
| Mar 31, 2021 | 6.90 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 3.50 Mn |
API Access
Emergent BioSolutions Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();